Cargando…
In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1)
Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163370/ https://www.ncbi.nlm.nih.gov/pubmed/21886907 http://dx.doi.org/10.3797/scipharm.1104-16 |
_version_ | 1782210939759624192 |
---|---|
author | Rafferty, Eamon P. Wylie, Alastair R. Elliott, Chris T. Chevallier, Olivier P. Grieve, David J. Green, Brian D. |
author_facet | Rafferty, Eamon P. Wylie, Alastair R. Elliott, Chris T. Chevallier, Olivier P. Grieve, David J. Green, Brian D. |
author_sort | Rafferty, Eamon P. |
collection | PubMed |
description | Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66–386%; P<0.05–0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes. |
format | Online Article Text |
id | pubmed-3163370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Österreichische Apotheker-Verlagsgesellschaft |
record_format | MEDLINE/PubMed |
spelling | pubmed-31633702011-09-01 In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) Rafferty, Eamon P. Wylie, Alastair R. Elliott, Chris T. Chevallier, Olivier P. Grieve, David J. Green, Brian D. Sci Pharm Short Communication Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66–386%; P<0.05–0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes. Österreichische Apotheker-Verlagsgesellschaft 2011 2011-06-09 /pmc/articles/PMC3163370/ /pubmed/21886907 http://dx.doi.org/10.3797/scipharm.1104-16 Text en © Rafferty et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Rafferty, Eamon P. Wylie, Alastair R. Elliott, Chris T. Chevallier, Olivier P. Grieve, David J. Green, Brian D. In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) |
title | In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) |
title_full | In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) |
title_fullStr | In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) |
title_full_unstemmed | In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) |
title_short | In Vitro and In Vivo Effects of Natural Putative Secretagogues of Glucagon-Like Peptide-1 (GLP-1) |
title_sort | in vitro and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (glp-1) |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163370/ https://www.ncbi.nlm.nih.gov/pubmed/21886907 http://dx.doi.org/10.3797/scipharm.1104-16 |
work_keys_str_mv | AT raffertyeamonp invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1 AT wyliealastairr invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1 AT elliottchrist invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1 AT chevallierolivierp invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1 AT grievedavidj invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1 AT greenbriand invitroandinvivoeffectsofnaturalputativesecretagoguesofglucagonlikepeptide1glp1 |